Strumento inattivo

Altre lingue Catalent, Inc.

Azioni

CTLT

US1488061029

Altre lingue

Silexion Therapeutics Announces Collaboration with Global Therapeutics Leader Catalent on Advanced siRNA Formulation Development & Clinical Manufacturing Activities	23/04
Lisata Therapeutics, Inc. Announces Research License with Catalent, Inc	15/04
Catalent, Inc. Appoints Susan Mahony, Marie-France Tschudin and Tim Walbert to Its Board of Directors	20/02
Experts explore the future of iPSC-based cell therapies	19/02
Ardena Holding NV completed the acquisition of Oral Solids Development and Small-Scale Manufacturing Facility in Somerset, NJ from Catalent, Inc..	04/02
Ardena Holding NV acquired Drug product manufacturing facility in Somerset, New Jersey of Catalent, Inc.	04/02
Ardena Holding NV acquired Drug product manufacturing facility in Somerset, New Jersey of Catalent, Inc.	04/02
Catalent, Inc.(NYSE:CTLT) dropped from S&P 500 Value	23/12
Catalent, Inc.(NYSE:CTLT) dropped from S&P 500 Ex-Financials, Real Estate, Utilities and Transportation Index	23/12
Catalent, Inc.(NYSE:CTLT) dropped from S&P 500 Equal Weighted	23/12
Catalent, Inc.(NYSE:CTLT) dropped from S&P 500 - Pharmaceuticals	23/12
Catalent, Inc.(NYSE:CTLT) dropped from S&P Global 1200	23/12
Catalent, Inc.(NYSE:CTLT) dropped from S&P 500 Health Care	23/12
Catalent, Inc.(NYSE:CTLT) dropped from S&P 500	23/12
Catalent, Inc.(NYSE:CTLT) dropped from S&P Composite 1500	23/12
Catalent, Inc.(NYSE:CTLT) dropped from S&P Pharmaceuticals Select Industry Index	23/12
Catalent, Inc.(NYSE:CTLT) dropped from S&P TMI Index	23/12
Catalent, Inc.(NYSE:CTLT) dropped from S&P Global BMI Index	23/12
Catalent, Inc.(NYSE:CTLT) dropped from FTSE All-World Index	20/12
Exchange-Traded Funds, Equity Futures Higher Pre-Bell Thursday as Investors Digest Fed Comments Ahead of Economic Data	19/12
Lennox International to Replace Catalent in S&P 500; BILL Holdings to Join S&P MidCap 400	19/12
Powell assomme Wall Street	19/12
En Direct des Marchés : EssilorLuxottica rempile avec Prada, grosse amende pour Seb, Micron se fait découper	19/12
Top Midday Stories: General Mills Lowers Adjusted EPS Guidance; Merck Strikes Licensing Deal With Chinese Drugmaker to Develop Weight-Loss Pill	18/12
Correction: Novo Nordisk Controlling Shareholder Completes $16.5 Billion Catalent Buyout	18/12

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Trascrizioni Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Catalent, Inc.

Azioni

CTLT

US1488061029

Altre lingue

Filtri